Myeloid Immune Cells CARrying a New Weapon Against Cancer

Chimeric antigen receptor (CAR) engineering for T cells and natural killer cells (NK) are now under clinical evaluation for the treatment of hematologic cancers. Although encouraging clinical results have been reported for hematologic diseases, pre-clinical studies in solid tumors have failed to pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos, Rodrigo Nalio, Couto, Samuel Campanelli Freitas, Oliveira, Theo Gremen M., Klinger, Paulo, Braga, Tarcio Teodoro, Rego, Eduardo Magalhães, Barbuto, José Alexandre M., Rocha, Vanderson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716000/
https://www.ncbi.nlm.nih.gov/pubmed/34977027
http://dx.doi.org/10.3389/fcell.2021.784421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716000/
https://www.ncbi.nlm.nih.gov/pubmed/34977027
http://dx.doi.org/10.3389/fcell.2021.784421

Ejemplares similares